Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Protheragen-ING
Holbrook, New York, United States
- Ownership
- Private
- Employees
- ~1
- Development stage
- Other
01
Overview
Protheragen-ING provides preclinical, clinical, and analytical services as an integrated drug development partner. It employs advanced AI-driven platforms for drug discovery, candidate optimization, and target identification, serving a diverse portfolio of global pharma and biotech clients. The majority of internal drug programs are at the preclinical stage, with an expanding client service business in GLP research, analysis, and medical device validation.
- Modalities
- Small moleculeMonoclonal antibodyAntibody-drug conjugateProteinCell therapyGene therapymRNA-based drugsPeptides
- Industry
- Drug Discovery Services
Beyond the preview
Go deeper on Protheragen-ING.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Protheragen-ING.